| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $416.4K | - | |
| CFO | 26.0K | $180.4K | - | |
| Dir | 7.0K | $48.6K | - | |
| Dir | 7.0K | $48.6K | - | |
| Dir | 7.0K | $48.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2016 | Neff Thomas B | Chief Executive Officer | Sale+OE | 37,798 | $18.99 | $717,595.03 | -0.6% | |
| Aug 26, 2016 | Neff Thomas B | Chief Executive Officer | Sale+OE | 37,798 | $17.80 | $672,705.43 | -0.4% | |
| Jul 27, 2016 | Neff Thomas B | Chief Executive Officer | Sale+OE | 37,798 | $18.38 | $694,547.95 | -0.4% | |
| Jul 13, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $17.50 | $472,419.00 | -0.3% | |
| Jun 29, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $16.02 | $432,574.00 | -0.3% | |
| Jun 15, 2016 | Cotroneo Pat | VP, Finance And CFO | Sell | 1,796 | $16.49 | $29,616.04 | -1.3% | |
| Jun 15, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $16.48 | $444,960.00 | -0.4% | |
| Jun 10, 2016 | Yu K Peony | Chief Medical Officer | Sell | 2,344 | $17.96 | $42,098.24 | -1.1% | |
| Jun 3, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $18.99 | $512,595.00 | -0.4% | |
| May 20, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $17.68 | $477,424.00 | -0.3% |